Skip to content

Earnings yield at other companies

Merck & Co. logo
Merck & Co.MRK
3%-4.7pp
Zoetis logo
ZoetisZTS
5.3%+1.9pp
Elanco Animal Health Inc. logo
Elanco Animal Health Inc.ELAN
-2%-9.3pp
Neogen logo
NeogenNEOG
-24.9%+3.4pp
Balchem logo
BalchemBCPC
2.9%+0.4pp
Mirum Pharmaceuticals, Inc. logo
Mirum Pharmaceuticals, Inc.MIRM
-14.3%-21.2pp

Other financials

Income statement

See full
Revenue$383.5M+10.3%
Gross profit$125.7M+20.2%
Operating income$44.7M+33.2%
Net income$24.0M+15.1%
EPS (diluted)$0.59+15.7%

Balance sheet

See full
Cash & equivalents$54.9M-9.0%
Total debt$32.3M+27.8%
Total equity$361.8M+36.0%
Total assets$1.4B+9.7%

Cash flow

See full
Operating cash flow$16.2M-62.4%
CapEx$15.3M+97.7%
Free cash flow$890.0K-97.5%

Valuation

See full
Market cap$1.27B+31.4%
Enterprise value$1.25B+33.9%
P/E13.4×-17.1×
P/S0.9×0.0×

Profitability

See full
Gross margin32.5%+0.9pp
Operating margin12%+4.0pp
Net margin6.3%+3.7pp
FCF margin0.9%-3.3pp

Returns & leverage

See full
Return on equity30.3%+18.5pp
Debt / equity0.1×0.0×
Current ratio3.2×+0.3×

Where this comes from

Calculated from Phibro Animal Health’s reported figures.

Based on trailing twelve months.

The official record: Phibro Animal Health’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Phibro Animal Health's earnings yield.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Phibro Animal Health's earnings yield?
Phibro Animal Health (PAHC) reported earnings yield of 4.2% in Q1 2026.
How has Phibro Animal Health's earnings yield changed year-over-year?
Phibro Animal Health's earnings yield increased by 15.6% year-over-year, from 3.7% to 4.2%.
What is the long-term trend for Phibro Animal Health's earnings yield?
Over 4 years (2021 to 2025), Phibro Animal Health's earnings yield has grown at a 0.8% compound annual growth rate (CAGR), from 4.6% to 4.8%.
What does earnings yield mean?
Trailing-twelve-month net income divided by market capitalization at the quarter end — the inverse of the P/E ratio, expressed as a percentage.